BIOMARIN PHARMA revenue breakdown overview

BIOMARIN PHARMA revenue for the last year amounted to 2.59 B CHF, the most of which — 2.59 B CHF — came from its highest performing source at the moment, Innovative Therapies, the year earlier bringing 2.04 B CHF. The greatest contribution to the revenue figure was made by United States — last year it brought BIOMARIN PHARMA 839.91 M CHF, and the year before that — 649.40 M CHF.